 LA JOLLA, Calif., April 15, 2021 GLOBE NEWSWIRE -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market NASDAQ:MNOV and the JASDAQ Market of the Tokyo Stock Exchange Code Number: 4875, today announced that MediciNova will participate in the UBS Global Healthcare Virtual Conference which will be held from May 24 - 26, 2021. Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey OBrien, JDMBA, Vice President and Executive Officer, will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through UBS. 